Groups Feed

The therapeutic landscape for metastatic cancer—cancer that has spread from its primary site to distant organs—has been dramatically altered by the advent of potent immunotherapies and highly specific targeted agents, moving the goal of treatment from simple palliation toward durable disease control and, in some cases, long-term remission.

These systemic therapies focus on either directly inhibiting the molecular drivers of tumor growth and survival or, more recently and profoundly, harnessing the patient's own immune system to recognize and eradicate malignant cells that have disseminated throughout the body.

Targeted therapy, such as kinase inhibitors, is predicated on the principle of precision medicine, requiring the identification of specific, actionable genetic mutations (e.g., *BRAF*, *EGFR*, *ALK* mutations) in the tumor. The efficacy of these drugs is often high initially but is commonly challenged by the development of acquired resistance mechanisms, necessitating sequential therapy or combination regimens. **Immunotherapy**, particularly the use of **immune checkpoint…

What is the Electronic Manufacturing Services sector

Over the past couple of decades, manufacturing of electronics has become increasingly specialized. Rather than every company making its own circuit boards, assembling components, doing testing and packaging, many firms now outsource those tasks to dedicated service providers. That’s the role played by the e

Welcome to our group Grand Strand Young R Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.